Effectiveness and Safety of Nadroparin Therapy in Preterm and Term Neonates with Venous Thromboembolism
Introduction: Optimal neonatal nadroparin dosages to treat venous thromboembolism (VTE) are unknown. Objective: To evaluate therapeutic nadroparin dosages to reach therapeutic target ranges (TTR: 0.5–1.0 International Unit (IU)/mL) and the effectiveness and safety of nadroparin in neonatal VTE. Meth...
Main Authors: | Jeanine Sol, Marit Boerma, Irene Klaassen, Sinno Simons, Bregje Witjes, Enno Wildschut, Irwin Reiss, Cornelia Heleen van Ommen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/7/1483 |
Similar Items
-
Spontaneous leg haematoma in a patient anticoagulated with nadroparin for suspected pulmonary thromboembolism
by: O Balbay, et al.
Published: (2004-02-01) -
Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children’s medical center
by: Yewei Chen, et al.
Published: (2024-01-01) -
Tinzaparin vs. Nadroparin Safety and Efficacy in Neurosurgery
by: Florian Wilhelmy, et al.
Published: (2021-05-01) -
Influence of fondaparinux versus nadroparin calcium thromboprophylaxis on clinical parameters following total knee arthroplasty
by: Zdravka Mihaljević, et al.
Published: (2016-01-01) -
Determination of factor Xa inhibition doses of low-molecular heparin, nadroparin and reviparin in urological patients
by: Pavlović Svetlana, et al.
Published: (2007-01-01)